RELATED CONTENT
NEWS
- BioCryst nods goalward to pharma partner, but M&A gets red card
- Generic Tricor could boost Lupin in the US but shadow on Antara
- Sun eyes operational efficiencies to unlock value in ex-URL generics
- Regulatory issues, emotive patents campaign to dominate Indian scene in 2013 amid opportunities
COMMENT
Other Informa Comment

